For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230607:nRSG8702Ba&default-theme=true
RNS Number : 8702B NetScientific PLC 07 June 2023
NetScientific plc
("NetScientific" or the "Company")
Director/PDMR Shareholding
NetScientific Plc (AIM: NSCI), the investment and commercialisation group
with an international portfolio of innovative life science, sustainability and
industrial technology companies, announces that on 6 June 2023, Dr. Jonathan
Robinson (Interim Non-Executive Chair and a Director of the Company) purchased
shares in NetScientific Plc into his Self Invested Personal Pension.
Following the purchase, Dr. Jonathan Robinson now holds 174,253 shares,
representing 0.74 Per cent. of the Company's issued share capital.
The following notification, made pursuant to Article 19(3) of the Market Abuse
Regulation, provides further details.
NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY OR PERSONS CLOSELY ASSOCIATED WITH THEM
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Dr. Jonathan Robinson
2 Reason for the notification
a) Position/status Director
b) Initial notification /Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name NetScientific plc
b) LEI 213800N5WD46G1Y7I458
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary Shares of £0.05 each
Identification code
GB00BN4R5Q82
b) Nature of the transaction Purchase of NSCI shares into SIPP
c) Price(s) and volume(s)
Price(s) Volume(s)
£0.5998 25,000 Ordinary Shares
d) Aggregated information
- Aggregated volume N/A
- Price
e) Date of the transaction 6 June 2023
f) Place of the transaction UK AIM
d)
Aggregated information
- Aggregated volume
- Price
N/A
e)
Date of the transaction
6 June 2023
f)
Place of the transaction
UK AIM
# # #
For more information, please contact:
NetScientific
Ilian Iliev, CEO Via Belvedere Communications
WH Ireland (NOMAD, Financial Adviser and Broker)
Chris Fielding / Darshan Patel +44 (0)20 7220 1666
Belvedere Communications
John West / Llew Angus +44 (0)20 3008 6867
About NetScientific
NetScientific plc (AIM: NSCI) is an investment and commercialisation group
with an international portfolio of innovative life science, sustainability and
technology companies.
NetScientific identifies, invests in, and builds high growth companies in the
UK and internationally. The company adds value through the proactive
management of its portfolio, progressing to key value inflection points, and
delivering investment returns through partial or full liquidity events.
NetScientific differentiates itself by employing a capital-light investment
approach, making judicial use of its balance sheet and syndicating investments
through its wholly owned VC subsidiary, EMV Capital. The group secures a
mixture of direct equity stakes and carried interest stakes in its portfolio
of companies, creating a lean structure that can support a large portfolio.
NetScientific is headquartered in London, United Kingdom, and is admitted to
trading on AIM, a market operated by the London Stock Exchange.
www.netscientific.net (http://www.netscientific.net/)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHSSSFAMEDSEFM